Warren Foust's most recent trade in Staar Surgical Co. was a trade of 58,651 Restricted Stock Units done . Disclosure was reported to the exchange on March 14, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Staar Surgical Co. | Warren Foust | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 58,651 | 58,651 | - | - | Restricted Stock Units | |
Staar Surgical Co. | Warren Foust | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 29,326 | 29,326 | - | - | Restricted Stock Units | |
Staar Surgical Co. | Warren Foust | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 8,175 | 16,350 | - | - | Restricted Stock Units | |
Staar Surgical Co. | Warren Foust | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 8,175 | 26,088 (0%) | 0% | 0 | Common Stock | |
Staar Surgical Co. | Warren Foust | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.02 per share. | 08 May 2024 | 2,418 | 17,913 (0%) | 0% | 41.0 | 99,186 | Common Stock |
Staar Surgical Co. | Warren Foust | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 24,525 | 24,525 | - | - | Restricted Stock Units | |
Staar Surgical Co. | Warren Foust | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 21,966 | 21,996 | - | - | Common Stock Options | |
Staar Surgical Co. | Warren Foust | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2023 | 37,567 | 37,567 | - | - | Common Stock Options | |
Staar Surgical Co. | Warren Foust | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2023 | 20,331 | 20,331 (0%) | 0% | 0 | Common Stock |